BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mou Y, Zhang Y, Wu J, Hu B, Zhang C, Duan C, Li B. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Front Oncol 2020;10:788. [PMID: 32528886 DOI: 10.3389/fonc.2020.00788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Yu A, Wang Z, Guo H, Yue C, Li N, Wang Y, Gao S, Hua C. Clinical implications and immunological features of iron metabolism-related gene prognostic signature in breast cancer.. [DOI: 10.21203/rs.3.rs-2317141/v1] [Reference Citation Analysis]
2 Xu C, Li W, Li T, Yuan J, Pang X, Liu T, Liang B, Cheng L, Sun X, Dong S. Iron metabolism-related genes reveal predictive value of acute coronary syndrome. Front Pharmacol 2022;13:1040845. [DOI: 10.3389/fphar.2022.1040845] [Reference Citation Analysis]
3 Xu Y, Tian R, Liu X, Song M, Liu L, Guo R, Li Z, Hu X, Zhang H, Ali L. Identification of Prognostic Fatty Acid Metabolism lncRNAs and Potential Molecular Targeting Drugs in Uveal Melanoma. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/3726351] [Reference Citation Analysis]
4 Gu X, Lai D, Liu S, Chen K, Zhang P, Chen B, Huang G, Cheng X, Lu C. Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease. Front Aging Neurosci 2022;14:949083. [DOI: 10.3389/fnagi.2022.949083] [Reference Citation Analysis]
5 Cai Q, Yu S, Zhao J, Ma D, Jiang L, Zhang X, Yu Z, Pandurangan A. The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5989419] [Reference Citation Analysis]
6 Guan Z, Liu S, Luo L, Wu Z, Lu S, Guan Z, Tao K. Identification of Ferroptosis-Related Genes as Biomarkers for Sarcoma. Front Cell Dev Biol 2022;10:847513. [PMID: 35309947 DOI: 10.3389/fcell.2022.847513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Al-Taie Z, Hannink M, Mitchem J, Papageorgiou C, Shyu CR. Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. Cancers (Basel) 2021;13:6278. [PMID: 34944904 DOI: 10.3390/cancers13246278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mo DC, Huang JF, Luo PH, Huang SX, Wang HL. Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials. Clin Immunol 2021;232:108876. [PMID: 34740840 DOI: 10.1016/j.clim.2021.108876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu S, Wang Z, Ye J, Mei S, Zhang J. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma. Front Oncol 2021;11:729103. [PMID: 34568059 DOI: 10.3389/fonc.2021.729103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chang X, Li D, Liu C, Zhang Z, Wang T. Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments. Cancer Cell Int 2021;21:193. [PMID: 33952272 DOI: 10.1186/s12935-021-01854-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Czyzyk-Krzeska MF, Landero Figueroa JA, Gulati S, Cunningham JT, Meller J, ShamsaeI B, Vemuri B, Plas DR. Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma. Genes (Basel) 2021;12:388. [PMID: 33803184 DOI: 10.3390/genes12030388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Markowitsch SD, Schupp P, Lauckner J, Vakhrusheva O, Slade KS, Mager R, Efferth T, Haferkamp A, Juengel E. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis. Cancers (Basel) 2020;12:E3150. [PMID: 33121039 DOI: 10.3390/cancers12113150] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
13 Zhang Y, Ma S, Wang M, Shi W, Hu Y. Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes. Front Oncol 2020;10:578933. [PMID: 33117716 DOI: 10.3389/fonc.2020.578933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]